2m 2m 2m 2m 2m 2m 2m
CNS PHARMA (CNSP)
NASDAQ
$5.75-$0.09 (-1.59%)
Price as of Sep 11, 2026 7:30 PM EDT- $8.5MMarket Cap
- -20.97%1-Year Change
- BiotechnologyIndustry
CNS PHARMA (CNSP)
$5.75-$0.09 (-1.59%)
CNSP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.84 | ||
Change | +$0.09 (+1.57%) | ||
Open | $5.84 | ||
High | $5.84 | ||
Low | $5.73 | ||
Previous Close | $5.75 | ||
Volume | 18,543 | ||
30-Day Average Volume | 9,125 | ||
1-Week Change | 1.92% | ||
1-Month Change | 6.18% | ||
1-Year Change | -20.97% | ||
3-Year Change | -99.99% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 1.5M | ||
Total Assets | $21.9M | ||
Market Cap | $8.5M | ||
Enterprise Value | -$11.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$3.5M | ||
EBIT | $0.00 | ||
EBITDA | $11,132.00 | ||
Net Working Capital | $18.2M | ||
EPS | -$0.38 | ||
Enterprise Value/EBITDA | -1,002 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -15 | ||
PEG | -0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 07/22/2025 | ||
Earnings & Revenue